DERMAFREEZE® is a professional cryosurgery system, indicated for the treatment of benign skin and mucous membrane lesions.
Portable, DERMAFREEZE® has a fast protocol and an excellent cost-benefit ratio.
Composition
DERMAFREEZE® propellants are fluorinated gases, non-toxic, odorless, non-flammable and non-polluting.
Presentation
DERMAFREEZE® is available in 2 versions: Dermafreeze 210 and Dermafreeze Mini.
Dermafreeze 210
Bottle with 210g of propellant product, sufficient for more than 200 short jets. Comes with 6 applicators with the following diameters: from 3mm to 12mm in diameter.
The number of lesions to be treated will vary according to the type of lesion.
Mini Version
Bottle with 40g of propellant product, for 40 short jets.
Comes with 3 applicators with diameters of 3, 5 and 7mm.
The number of lesions to be treated will vary according to the type of lesion.
What is in the Kit?
Tube with cryogenic gas
Extension tube
Applicators (cones)
Instruction Manual
APLICCATORS
The applicators are these conical shaped pieces, and are an important part of your Dermafreeze.
They serve to limit the action of the cryogenic product in the area to be treated.
The Dermafreeze Mini comes with 3 applicators (3, 5, and 7mm)
The Dermafreeze 210 comes with 6 applicators (3, 4, 5, 7, 9 and 12mm)
The applicators can be sterilized in an autoclave or in a solution, if preferred.
Apliccations
Dermafreeze is indicated for the treatment of benign lesions of the skin and mucous membranes.
Types of Lesions Treated
Dermafreeze treats a wide range of lesions, including warts, solar melanosis, keratoses, epithelial nevus, molluscum contagiosum, guttate leukoderma, HPV warts, anogenital lesions, condyloma acuminata, among others.
Temperature
Based on scientific studies, Dermafreeze freezes lesions at a temperature of -45oC.
How to Use
Access the Use Protocol page for detailed information on use.
Contraindication
The use of cryosurgery, including DERMAFREEZE, is not recommended for patients with poor peripheral circulation, coagulation disorders, active infections or open wounds at the site, extreme sensitivity to cold, history of abnormal healing (such as keloids) or lesions suspected of malignancy. Each case must be assessed individually, and in doubtful situations, the patient must be referred to a physician before the procedure.
Storage
Dermafreeze must be stored at room temperature.
Shelf life
Dermafreeze is valid for 3 years.
Anvisa Registration
Dermafreeze is a product registered with Anvisa No. 80409950001.
International Quality Certification ISO 13485
Dermafreeze has international quality certification ISO 13485.
Technical Manager
Eng. Luiz Lamardo Júnior – CREA-SP 0600219912